Tvardi Therapeutics TVRD
NASDAQ TVRD
$1.86 +0.03 (+1.64%)
At close: Aug 21, 2026 · 4:00 PM EDT

Tvardi Therapeutics (TVRD) Amortizatization of Intangibles (2016 - 2026)

Tvardi Therapeutics (TVRD) posted Amortizatization of Intangibles of $35000.0 for Q1 2026, up 2.94% sequentially from $34000.0 in Q4 2025, and down 50.7% YoY from $71000.0 in Q1 2025.

Tvardi Therapeutics (TVRD) Amortizatization of Intangibles (2016 - 2026) Analysis & Trends

Tvardi Therapeutics has reported Amortizatization of Intangibles for 11 years, with the latest figure at $35000.0 in Q1 2026.

  • Quarterly Amortizatization of Intangibles fell 50.7% year-over-year to $35000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $164000.0 (up 57.69% YoY) and the FY2025 annual result came in at $200000.0, down 63.17% from the prior year.
  • Amortizatization of Intangibles climbed to $35000.0 in Q1 2026 per TVRD's latest filing, from $34000.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $510000.0 in Q1 2024 and troughed at -$292000.0 in Q1 2022.
  • A 5-year average of $60933.3 and a median of $35000.0 in 2026 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles jumped 442.55% in 2024, then slumped 86.08% in 2025.
  • Over 5 years, Amortizatization of Intangibles stood at $234000.0 in 2022, then increased by 2.99% to $241000.0 in 2023, then slumped by 86.31% to $33000.0 in 2024, then gained by 3.03% to $34000.0 in 2025, then increased by 2.94% to $35000.0 in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $35000.0, $34000.0, and $25000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Tvardi Therapeutics 17.36 Mn 17.36 Mn - 14,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 35,000.00
Mar 31, 2026 35,000.00
Dec 31, 2025 34,000.00
Dec 31, 2025 34,000.00
Sep 30, 2025 25,000.00
Sep 30, 2025 25,000.00
Jun 30, 2025 70,000.00
Jun 30, 2025 70,000.00
Mar 31, 2025 71,000.00
Mar 31, 2025 71,000.00
Jun 30, 2024 33,000.00
Jun 30, 2024 33,000.00
Mar 31, 2024 510,000.00
Mar 31, 2024 510,000.00
Dec 31, 2023 241,000.00
Dec 31, 2023 241,000.00
Sep 30, 2023 103,000.00
Sep 30, 2023 103,000.00
Jun 30, 2023 -38,000.00
Jun 30, 2023 -38,000.00